1. Singapore Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
HC Surgical Specialists Ltd

HC Surgical Specialists Ltd

SSGX:1B1
0.36
SGD
+0.01
(+1.41%)
52.15MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.05
0.05
0.04
0.07
0.11
0.12
0.11
0.16
0.13
0.13
0.12
0.12
- -
- -
Basic EPS, GAAP
0.02
0.02
0.01
0.01
0.03
0.05
0.03
0.05
0.04
0.02
0.03
0.05
- -
- -
Free Cash Flow per Basic Share
0.03
0.02
0.01
- -
0.04
0.04
0.03
0.07
0.05
0.04
0.04
0.04
- -
- -
Dividend per Share
0.02
0.03
- -
0.02
0.02
0.02
0.02
0.02
0.04
0.02
0.02
0.02
- -
- -
Book Value per Share
0.01
- -
0.01
0.09
0.11
0.13
0.11
0.07
0.07
0.08
0.1
0.14
- -
- -
Tangible Book Value per Share
0.01
- -
0.01
0.07
0.08
0.09
0.08
0.03
0.05
0.06
0.07
0.11
- -
- -
Basic Weighted Avg Shares
146
146
194
127
149
149
150
150
149
149
152
154
153
153
Sales/Revenue/Turnover
7
7
8
9
16
18
17
23
19
19
19
19
- -
- -
Operating Margin (%)
67.93
65.02
64.68
43.36
45.01
46.17
45.79
49.68
44.51
42.52
37.43
37.05
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
1
2
2
2
2
2
- -
- -
Net Income, GAAP
3
3
3
1
4
7
4
8
6
3
4
8
- -
- -
Effective Tax Rate (%)
9.57
9.25
17.22
17.76
9.11
10.78
14.74
13.77
12.19
26.35
22.17
0.24
- -
- -
Profit Margin (%)
49.95
47.34
34.63
13.8
27.86
39.34
23.84
34.25
33.04
15.3
20.45
44.16
- -
- -
Working Capital
1
- -
2
9
2
3
5
7
1
1
- -
3
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
7
6
4
3
2
1
- -
- -
Total Equity
1
- -
2
14
17
20
17
11
11
12
14
21
- -
- -
Return on Invested Capital (%)
- -
338.45
197.31
47.33
38.17
38.42
28.31
43.83
38.43
31.78
28.07
30.7
- -
- -
Return on Capital (%)
- -
434.66
185.12
19.07
20.72
30.07
16.83
34.02
33.71
16.98
21.32
38.91
- -
- -
Return on Common Equity (%)
- -
461.71
214.5
16.37
29.24
39.4
22.06
61.29
61.27
25.27
28.71
47.36
- -
- -

Capital Structure

SGD

•

in mil. unless spec.
May'25
Nov'26
May'26
ST Debt
1
1
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
153
153
153
Market Capitalization
44
52
58

Working Capital

SGD

•

in mil. unless spec.
May'25
Nov'26
May'26
Total Current Assets
8
9
- -
Cash, Cash Equivalents & STI
6
7
- -
Accounts Receivable, Net
1
1
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
5
- -
Payables & Accruals
- -
- -
- -
ST Debt
1
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
19
2025
- -
- -
19
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.03
2025
- -
- -
0.05
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.02
2025
- -
- -
0.02
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sieu Min Heah
Full Time Employees
18
Sector
Health services
Industry
Medical/Nursing services
Address
233 River Valley Road Singapore CE Singapore 238291
IPO Date
Nov 3, 2016
Website
hcsurgicalspecialists.com
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
HC Surgical Specialists Limited is a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of 16 clinics located throughout Singapore. The company offers treatment services for conditions such as haemorrhoids, anal fissures, hernias, anal abscesses, cholecystitis, anal fistulas, appendicitis, colorectal cancer, lipomas, cysts, gastric cancer, vein laser vascular treatments, and laparoscopy; orthopedic services comprising joint pain management, sports injuries, osteoarthritis, rotator cuff tears, trigger finger treatments, wounds and lumps, joint replacements, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections; home care services including medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, pre-employment check-ups, public health preparedness clinic schemes, swab and send home programs, community health assist schemes, and COVID-19 swab tests; and diagnostic tests such as blood tests, X-rays, ultrasounds, CT scans, and MRIs. It operates in the healthcare sector, targeting private patients through Medisave-accredited clinics situated in central Singapore, residential heartlands, and major private hospitals, with accessibility enhanced by proximity to public transportation. Founded in 2015 and headquartered at 233 River Valley Road, No. B1-04/05, RV Point, Singapore 238291, the company manages subsidiaries and associates including recent stakes in orthopedic and endoscopy entities. In fiscal year 2025 ended May 31, HC Surgical Specialists recorded a 119% surge in earnings to $8.4 million, driven by fair value gains, contributions from a new subsidiary, and orthopedic expansion including the opening of Total Orthopaedic Care & Surgery (Orchard), HC Orthopaedics & Surgical Centre (Tampines), addition of orthopedic surgeons, and a 35% stake in Total Orthopaedics Pte. Ltd. with forward purchase options; it also completed the acquisition of the remaining 49% equity interest in GMH Endoscopy & Surgery Pte. Ltd., disposed of 51% in HMC Medical Pte. Ltd., incorporated subsidiaries such as HC (Ming) Pte. Ltd., and restrategized operations by closing the Anchorvale centre to focus on Siglap while pursuing local and overseas growth opportunities.